Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

2.79USD
16 Apr 2014
Price Change (% chg)

$0.18 (+6.90%)
Prev Close
$2.61
Open
$2.64
Day's High
$2.81
Day's Low
$2.60
Volume
1,717,328
Avg. Vol
1,911,839
52-wk High
$8.49
52-wk Low
$2.26

Search Stocks
HALAK BRIAN K
Trading Date Type Shares Traded Price Shares Held
17 Jan 2013 Buy 66,462 $0.00 6,017,025
17 Jan 2013 Sell 1,000,000 $0.00 6,017,025
30 May 2012 Sell 1,200,000 $0.00 6,950,563
30 May 2012 Buy 93,434 $0.00 6,950,563

Institutional Holders

% Shares Owned: 97.84%
# of Holders: 124
Total Shares Held: 94,701,640
3 Mo. Net Change: 5,420,330
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

David Scheer

60 2010 Chairman of the Board

Milind Deshpande

56 2013 President, Chief Executive Officer, Director

Mary Kay Fenton

48 2010 Chief Financial Officer, Senior Vice President

Gautam Shah

56 2012 Executive Vice President, Chief Compliance Officer

David Apelian

47 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

48 2012 Senior Vice President, Chief Commercial Officer

Michael Kishbauch

64 2013 Director

Jason Fisherman

55 2000 Independent Director

Gary Frashier

75 2008 Independent Director

Kurt Graves

45 2012 Independent Director

Dennis Liotta

65 2008 Independent Director

Robert Van Nostrand

56 2007 Independent Director

Nicole Vitullo

55 2010 Independent Director
Search Stocks